Compare Hims and Hers Health Inc (HIMS) vs CarMax, Inc (KMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs CarMax, Inc — how do they compare? Hims and Hers Health Inc trades at $32.75 (market cap $7.57B), while CarMax, Inc trades at $55.91 (market cap $7.93B). The key difference: Hims and Hers Health Inc and CarMax, Inc are close in size by market cap, and CarMax, Inc is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals.
| HIMS | KMX | |
|---|---|---|
Market Cap | $7.57B | $7.93B |
Sector | Health | Consumer Cyclical |
52-Week High | $66.18 | $63.53 |
52-Week Low | $14.52 | $30.88 |
Enterprise Value | $7.95B | $26.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a mixed technical picture showing bullish moving averages but neutral oscillators. Fundamentally, the company reported 2025 revenue of $2.35 billion and net income of $128.37 million, though 2026 projections indicate a net loss. Recent news highlights executive departures and anticipation for Q2 2026 earnings on August 10, 2026.
The investment outlook is cautiously optimistic, supported by a 35% analyst buy rating and a $33.57 consensus price target. Key opportunities include growth in the weight-loss drug segment and international expansion. Risks involve profitability volatility, intense competition, and reliance on telehealth regulatory frameworks. The stock's valuation remains elevated with a P/E of 57.14, demanding strong future earnings growth to justify current levels.
CarMax (KMX) trades at $57.61, up 0.49% on the day, with a bullish technical outlook supported by moving averages and a strong ADX signal. Recent Q1 2026 earnings beat expectations, driven by cost control and revenue growth, though net income margins remain thin at 0.84%. The company's four-pillar strategy focuses on volume, digital sales, and efficiency, with positive analyst coverage highlighting value and momentum potential.
The stock's upside is supported by operational improvements and insider buying, but risks include high debt levels, margin pressure, and a pending legal investigation. Analyst consensus is cautious with a $48.91 price target below the current price, suggesting limited near-term upside amid execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About CarMax, Inc
CarMax sells, finances, and services used and new cars through a chain of over 230 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue and wholesale about 13%, with the remaining portion composed of extended service plans and repair. In fiscal 2022, the company retailed and wholesaled 924,338 and 706,212 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the U.S. but still estimates that it has only about 4% U.S. market share of vehicles 0-10 years old in 2021. It seeks over 5% share by the end of calendar 2025 and revenue between $33 billion to $45 billion by fiscal 2026. CarMax is based in Richmond, Virginia.
Read more on KMX →
